invasieve schimmelinfectie (aangetoond of verdenking)
Advices
| Priority | Medication | Remarks |
|---|---|---|
|
Priority: 1st choice |
Medication: voriconazol iv +
ambisome iv |
Remarks:
SWAB remarks dosering voriconazol: https://www.kinderformularium.nl/geneesmiddel/96/voriconazol Gezien grote inter- en intra- individuele variaties in spiegelbepaling van voriconazol genoodzaakt. Bij contra-indicaties voor voriconazol of niet op spiegel komen is isavuconazol een alternatief (dosering isavuconazol: Geneesmiddel | Isavuconazol | Kinderformularium dosering ambisome: https://www.kinderformularium.nl/geneesmiddel/2519/amfotericine-b-liposomaal indicatie systemisch mycosen |
|
Priority: 2nd choice |
Medication: voriconazol iv +
micafungin iv |
Remarks:
SWAB remarks dosering voriconazol: https://www.kinderformularium.nl/geneesmiddel/96/voriconazol Gezien grote inter- en intra-individuele variaties is TDM van voriconazol genoodzaakt. dosering micafungin: Geneesmiddel | Micafungine | Kinderformularium |
Sources
-
http://www.swab.nl/swab/cms3.nsf/uploads/3AA7A56CE879587BC12581F80061297F/$FILE/SWAB%20Richtlijn%20Mycosen%202017%20(final).pdf
SWAB richtlijn invasieve schimmelinfecties (december 2017)
-
Pubmed.gov publication # 18462102
Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.
-
H5-Antibiotica-mei-2015.pdf
Skion supportive care richtlijn
Antimicrobial resources
The following antimicrobial agents have been used in these recommendations:
- voriconazol
- ambisome
- micafungin
Menu position
Metadata
Swab vid: G-388431.3
Updated: 03/19/2025 - 15:03
Status: Published